Viewing Study NCT00408759


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-02-21 @ 8:30 AM
Study NCT ID: NCT00408759
Status: UNKNOWN
Last Update Posted: 2006-12-07
First Post: 2006-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Sponsor: Bnai Zion Medical Center
Organization:

Study Overview

Official Title: Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Status: UNKNOWN
Status Verified Date: 2006-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.
Detailed Description: 10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: